Correlation between carbapenem consumption and resistance to carbapenems among Enterobacteriaceae isolates collected from patients with intra-abdominal infections at five medical centers in Taiwan, 2006-2010

International Journal of Antimicrobial Agents

Volumn 40, Issue SUPPL. 1, 2012, Pages

  Ho, Cheng Mao ^a,e,j   Ho, Mao Wang ^a,e,j   Liu, Yung Ching ^b,l   Toh, Han Siong ^c   Lee, Yu Lin ^d,m   Liu, Yuag Meng ^d,e   Huang, Chi Chang ^f   Lu, Po Liang ^g,n   Liu, Chun Eng ^d   Chen, Yen Hsu ^g,n   Ko, Wen Chien ^f,o   Tang, Hung Jen ^c,p   Yu, Kwok Woon ^h   Chen, Yao Shen ^i,m,q   Chuang, Yin Ching ^c   Wang, Jen Hsien ^j   Hsueh, Po Ren ^k  

^a Division of Infectious Diseases   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c CHI MEI MEDICAL CENTER   (Taiwan)

^d CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^e CHINA MEDICAL UNIVERSITY   (Taiwan)

^f NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^g KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^h TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

ⁱ KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^j CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^k NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^l TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^m NATIONAL YANG MING UNIVERSITY   (Taiwan)

ⁿ KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^o NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^p CHIA NAN UNIVERSITY OF PHARMACY AND SCIENCE   (Taiwan)

^q NATIONAL KAOHSIUNG NORMAL UNIVERSITY   (Taiwan)

more..

Author keywords

Carbapenem consumption; Carbapenem resistance; Enterobacteriaceae; Intra abdominal infections; SMART

Indexed keywords

CARBAPENEM DERIVATIVE; ERTAPENEM; IMIPENEM; MEROPENEM;

ABDOMINAL INFECTION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CONTROLLED STUDY; CORRELATIONAL STUDY; DRUG USE; ENTEROBACTER; ENTEROBACTERIACEAE; ESCHERICHIA COLI; KLEBSIELLA; NONHUMAN; PRIORITY JOURNAL; TAIWAN; TREND STUDY;

ANTI-BACTERIAL AGENTS; BETA-LACTAMS; CARBAPENEMS; DRUG RESISTANCE, BACTERIAL; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; HUMANS; INTRAABDOMINAL INFECTIONS; LINEAR MODELS; MICROBIAL SENSITIVITY TESTS; PREVALENCE; PROSPECTIVE STUDIES; TAIWAN; THIENAMYCINS;

EID: 84863436986     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/S0924-8579(12)70006-7     Document Type: Article

References (22)

1. HF Chambers, FR Deleo Waves of resistance: Staphylococcus aureus in the antibiotic era Nat Rev Microbiol 7 2009 629 641
2. CM Ho, PR Hsueh, CY Liu, SY Lee, TS Chiueh, JM Shyr et al. Prevalence and accessory gene regulator (agr) analysis of vancomycin-intermediate Staphylococcus aureus among methicillin-resistant isolates in Taiwan-SMART program, 2003 Eur J Clin Microbiol Infect Dis 29 2010 383 389
3. KS Thomson Extended-spectrum-beta-lactamase, AmpC, and carbapenemase issues J Clin Microbiol 48 2010 1019 1025
4. J Davies, D Davies Origins and evolution of antibiotic resistance Microbiol Mol Biol Rev 74 2010 417 433
5. PR Hsueh, CY Liu, KT Luh Current status of antimicrobial resistance in Taiwan Emerg Infect Dis 8 2002 132 137
6. TR Walsh Emerging carbapenemases: a global perspective Int J Antimicrob Agents 36 Suppl 3 2010 S8 14
7. SP Hawser, SK Bouchillon, DJ Hoban, RE Badal, PR Hsueh, DL Paterson Emergence of high levels of extended-spectrum-beta-lactamase-producing Gram-negative bacilli in the Asia-Pacific region: data from the Study for Monitoring Antimicrobial Resistance Trends (SMART) program, 2007 Antimicrob Agents Chemother 53 2009 3280 3284
8. PR Hsueh, RE Badal, SP Hawser, DJ Hoban, SK Bouchillon, Y Ni et al. Epidemiology and antimicrobial susceptibility profiles of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections in the Asia-Pacific region: 2008 results from SMART (Study for Monitoring Antimicrobial Resistance Trends) Int J Antimicrob Agents 36 2010 408 414
9. PR Hsueh, TA Snyder, MJ Dinubile, V Satischandran, K McCarroll, JW Chow In vitro susceptibilities of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections in the Asia-Pacific region: 2004 results from SMART (Study for Monitoring Antimicrobial Resistance Trends) Int J Antimicrob Agents 28 2006 238 243 (Pubitemid 44223984)
10. YH Chen, PR Hsueh, RE Badal, SP Hawser, DJ Hoban, SK Bouchillon et al. Antimicrobial susceptibility profiles of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections in the Asia-Pacific region according to currently established susceptibility interpretive criteria J Infect 62 2011 280 291
11. WC Ko, PR Hsueh Increasing extended-spectrum beta-lactamase production and quinolone resistance among Gram-negative bacilli causing intra-abdominal infections in the Asia/Pacific region: data from the SMART Study 2002-2006 J Infect 59 2009 95 103
12. Clinical and Laboratory Standards Institute Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Document M07-A8 2009 CLSI Wayne, PA
13. Clinical and Laboratory Standards Institute Performance standards for antimicrobial susceptibility testing. Twentieth informational supplement. Document M100-S20 2010 CLSI Wayne, PA
14. Clinical and Laboratory Standards Institute Performance standards for antimicrobial susceptibility testing. Twenty-first informational supplement. Document M100-S21 2011 CLSI Wayne, PA
15. KM Papp-Wallace, A Endimiani, MA Taracila, RA Bonomo Carbapenems: past, present, and future Antimicrob Agents Chemother 55 2011 4943 4960
16. GA Jacoby, LS Munoz-Price The new beta-lactamases N Engl J Med 352 2005 380 391
17. N Gupta, BM Limbago, JB Patel, AJ Kallen Carbapenem-resistant Enterobacteriaceae: epidemiology and prevention Clin Infect Dis 53 2011 60 67
18. M Doumith, MJ Ellington, DM Livermore, N Woodford Molecular mechanisms disrupting porin expression in ertapenem-resistant Klebsiella and Enterobacter spp. clinical isolates from the UK J Antimicrob Chemother 63 2009 659 667
19. CM Pillar, MK Torres, NP Brown, D Shah, DF Sahm In vitro activity of doripenem, a carbapenem for the treatment of challenging infections caused by Gram-negative bacteria, against recent clinical isolates from the United States Antimicrob Agents Chemother 52 2008 4388 4399
20. TR Fritsche, MG Stilwell, RN Jones Antimicrobial activity of doripenem (S-4661): a global surveillance report (2003) Clin Microbiol Infect 11 2005 974 984 (Pubitemid 41748931)
21. RE Mendes, PR Rhomberg, JM Bell, JD Turnidge, HS Sader Doripenem activity tested against a global collection of Enterobacteriaceae, including isolates resistant to other extended-spectrum agents Diagn Microbiol Infect Dis 63 2009 415 425
22. LR Peterson Squeezing the antibiotic balloon: the impact of antimicrobial classes on emerging resistance Clin Microbiol Infect 11 Suppl 5 2005 4 16 (Pubitemid 41341707)